SOURCE: Clinquest Group BV

May 20, 2008 05:33 ET

Clinquest Group appoints Dr. Louis Van de Ven, MD, Ph.D. as CEO/CMO of its subsidiary Clinquest Europe BV

AMSTERDAM, NETHERLANDS--(Marketwire - May 20, 2008) -


Amsterdam, the Netherlands, May 20th 2008

Clinquest Group, an international Healthcare Product Development Organization (PDO) has appointed Dr Louis Van de Ven, MD, Ph.D. as Chief Executive and Chief Medical Officer of its subsidiary Clinquest Europe BV (Oss, The Netherlands).

Dr. Louis Van de Ven joins Clinquest Europe from Merck Netherlands where he held the position of Medical Director responsible for clinical research and medical affairs for Europe. He has over twenty years of experience managing Phase I-IV clinical trials, including many pivotal studies resulting in marketing approvals of cardiovascular, gynecological, oncological and immunological drugs.

Dr. Van de Ven holds an MD degree from the Erasmus University, as well as a PhD degree from the University of Groningen (cardiovascular pharmacology). He is a board certified internist.

"I am very pleased to expand our senior management team with such an experienced and highly qualified senior executive", says Chief Executive Officer Cees Wortel, MD, Ph.D. "Louis will strengthen our organization with his extensive experience across the entire drug development process and his proven achievements in drug approvals. In collaboration with our international subsidiaries, Louis will make an important contribution to achieving Clinquest's growth objectives in Europe. With Louis in our team, we are now able to offer a full range of highly experienced consultants in all fields of clinical research, including Clinical Operations, Statistics, Data Management, QC/QA and Pharmacovigilance."

About Clinquest Group

The Clinquest Group is a trusted Healthcare Product Development Organization (PDO), which offers comprehensive product development services to the bio-pharmaceutical, medical device, diagnostics and medical data industries worldwide. Clinquest provides high-level strategic consulting as well as hands-on implementation services. Clinquest is recognized as a leader in the development of new, breakthrough technologies, first-in-man clinical trials and complex clinical studies. The Clinquest Group operates through three wholly-owned subsidiaries: Clinquest Inc., Clinquest Europe and Clinquest Pharmaceutical Innovations. The company is headquartered in Amsterdam, the Netherlands, and has offices in the USA and Singapore.

About Clinquest Europe BV

Clinquest Europe BV delivers contract research in Clinical Development, program development, data management, biometrics, staffing, product development, medical consulting and QA/QC services in Europe. Clinquest Europe is based in Oss, the Netherlands.

==================
Media
contact:

Dr. L.L.M. Van de Ven
T: +31 412 405830
e-mail lvandeven@clinquest.com
www.clinquest.com




Copyright © Hugin AS 2008. All rights reserved.

Contact Information